OPN-662

A Phase 1b, Dose Escalation/Dose Expansion, Multicenter, Open-Label Study to Assess the Safety and Tolerability of OPN-6602 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and/or Refractory Multiple Myeloma

Arms / Cohorts

Experimental:Dose Escalation

Status
Status not available
Treatments
Treatments not available
Criteria
Criteria not available

Accepting patients

Experimental:Dose Escalation: OPN-6602 + Dexamethasone

Status
Status not available
Treatments
Treatments not available
Criteria
Criteria not available

Accepting patients

Experimental:Dose Expansion

Status
Status not available
Treatments
Treatments not available
Criteria
Criteria not available

Not yet accepting

Patient Screener(888) 850-0650

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.